Plain-English translation of NCT07809438 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
United States
Phase
Testing effectiveness
Sponsor
Michael J. Fox Foundation for Parkinson's Research
Enrollment target
~25 participants
Started
September 2025
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lianne Ramia
Institute for Neurodegenerative Disorders
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.